MIRA INFORM REPORT

 

 

Report Date :

16.08.2014

 

IDENTIFICATION DETAILS

 

Name :

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

 

 

Registered Office :

407-408, Sharda Chambers, New Marine Lines, Mumbai - 400020, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

24.09.2002

 

 

Com. Reg. No.:

11-137329

 

 

Capital Investment / Paid-up Capital :

Rs. 5.000 Millions 

 

 

CIN No.:

[Company Identification No.]

 U24230MH2002PTC137329

 

 

PAN No.:

[Permanent Account No.]

AABCB9286B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Pharmaceutical Raw Material, they do Manufacturing through Job Work.

 

 

No. of Employees :

50 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1700000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct 

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

General financial position of the company seems to be sound and healthy. Profitability of the company is fair.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Tejas Shah

Designation :

Director

Contact No.:

91-22-40560560

Date :

13.08.2014

 

 

LOCATIONS

 

Registered Office :

407-408, Sharda Chambers, New Marine Lines, Mumbai - 400020, Maharashtra, India

Tel. No.:

91-22-40560560

Fax No.:

91-22-40560555

E-Mail :

bdrpharma@vsnl.net

 

 

Regional Office :

Located at:

 

v      Ahmedabad

 

 

Factory / Sites :

Also located at:

 

v      Surat

v      Baroda

 

 

DIRECTORS

 

As on: 30.09.2013

 

Name :

Mr. Dharmesh Mahendra Shah

Designation :

Director

Address :

2301, Sterling Towers, H G Marg, Gamdevi, Mumbai-400007, Maharashtra, India

Date of Birth/Age :

15.03.1966

Qualification :

Chemical Engineer

Date of Appointment :

24.09.2002

PAN No.:

AAHPS8208B

DIN No.:

00452961

 

 

Name :

Mr. Vijay Chhabildas Shah

Designation :

Director

Address :

501, Panchsheel, 5th Floor, C Road, Churchgate, Mumbai-400020, Maharashtra, India

Date of Birth/Age :

19.02.1945

Date of Appointment :

05.01.2004

DIN No.:

00453308

 

 

Name :

Mr. Tejash Vijay Shah

Designation :

Director

Address :

Room No. A 29, B 51-52, Lal Sing Building, Lohar Chawl, Kalbadevi, Mumbai- 400002, Maharashtra, India

Date of Birth/Age :

11.08.1978

Date of Appointment :

16.01.2008

PAN No.:

ACAPS6530M

DIN No.:

01862033

 

 

Name :

Mr. Raheel Dharmesh Shah

Designation :

Director

Address :

2301-A,2302-B, Sterling Towers, Harischandra Goreg, Aonkar Narg, Gamdevi, Mumbai-400007, Maharashtra, India

Date of Birth/Age :

20.01.1990

Date of Appointment :

27.07.2011

PAN No.:

BHSPS0210C

DIN No.:

03582861

 

 

Name :

Dr. Arvind M. Badiger

Designation :

Director

Address :

Flat No. A801, Ashwarya Complex, Near Vegetable Market, Ellora Park, Odhavpura, Vadodara – 3907, Gujarat, India

Date of Birth/Age :

24.06.1974

Date of Appointment :

15.12.2012

PAN No.:

AGGPB6718E

DIN No.:

06540340

           

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2013

 

Names of Shareholders

 

No. of Shares

Dharmesh Mahendra Shah

 

4900

Binita Dharmesh Shah

 

347900

M Sharmishta Shah

 

147000

Vijay Chabildas Shah

 

100

Suresh Chabildas Shah

 

100

 

 

 

Total

 

500000

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2013

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Pharmaceutical Raw Material, they do Manufacturing through Job Work.

 

 

Terms :

 

Selling :

Cash, Credit

 

 

Purchasing :

Cash, Credit

 

 

GENERAL INFORMATION

 

No. of Employees :

50 (Approximately)

 

 

Bankers :

·         ABN Amro Bank N.V., 7th Floor, Sakhar Bhavan, Nariman Point, Mumbai – 400 021, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

LONG TERM BORROWINGS

 

 

Other loans and advance

0.443

1.403

 

 

 

Total

0.443

1.403

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Lalit Mehta and Company

Chartered Accountants

Address :

101, Apollo Arcade, R.K. Singh Marg, Off P.P. Road, Near Sona Udyog, Andheri (East), Mumbai – 400069, Maharashtra, India

PAN No.:

AABPM6331K

 

 

Associates :

·         Sunshine Organics Private Limited

(CIN No: U24110MH1988PTC048981)

·         BDR Life Sciences Private Limited

(CIN No: U24230GJ1993PTC020258)

·         Innova Life Sciences Private Limited

(CIN No: U24230MH2003PTC143625)

·         Virdev Intermediates Private Limited

(CIN No: U24230GJ1994PTC021189)

·         Mepromax Life Sciences Private Limited

(CIN No: U24231GJ2005PTC021189)

·         B K Life Sciences Private Limited

(CIN No: U24239MH2006PTC164688)

·         Mepro Laboratories

·         Mepro Pharmaceuticals Private Limited

·         Lyka Bdr International Limited

 

 

CAPITAL STRUCTURE

 

As on: 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs. 10.000 Millions

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs. 5.000 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

5.000

5.000

5.000

(b) Reserves & Surplus

431.527

304.555

218.887

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

436.527

309.555

223.887

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

18.362

26.380

23.410

(b) Deferred tax liabilities (Net)

1.915

0.504

0.290

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

20.277

26.884

23.700

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

753.243

713.801

0.000

(c) Other current liabilities

38.271

29.428

659.589

(d) Short-term provisions

139.500

89.500

58.700

Total Current Liabilities (4)

931.014

832.729

718.289

 

 

 

 

TOTAL

1387.818

1169.168

965.876

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

68.604

19.080

9.661

(ii) Intangible Assets

0.116

0.011

0.019

(iii) Capital work-in-progress

9.144

38.906

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

85.482

74.966

74.966

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

164.455

95.811

6.912

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

327.801

228.774

91.558

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

147.830

141.274

84.225

(c) Trade receivables

508.721

450.606

444.018

(d) Cash and cash equivalents

380.884

343.438

279.495

(e) Short-term loans and advances

22.582

5.076

66.580

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1060.017

940.394

874.318

 

 

 

 

TOTAL

1387.818

1169.168

965.876

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

1815.171

1536.945

1222.765

 

 

Other Income

62.023

46.204

20.095

 

 

TOTAL                                    

1877.194

1583.149

1242.860

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

1662.566

1442.976

1169.791

 

 

 

 

 

 

PROFIT BEFORE TAX

214.628

140.173

73.069

 

 

 

 

 

Less

TAX                                                                 

70.223

45.788

24.955

 

 

 

 

 

 

PROFIT AFTER TAX

144.405

94.385

48.114

 

 

 

 

 

 

Earnings Per Share (Rs.)

288.81

188.77

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

7.69

5.96

3.87

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

11.82

9.12

5.98

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

16.60

13.28

8.20

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.49

0.45

0.33

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.04

0.09

0.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.14

1.13

1.22

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

5.000

5.000

5.000

Reserves & Surplus

218.887

304.555

431.527

Net worth

223.887

309.555

436.527

 

 

 

 

long-term borrowings

23.410

26.380

18.362

Short term borrowings

0.000

0.000

0.000

Total borrowings

23.410

26.380

18.362

Debt/Equity ratio

0.105

0.085

0.042

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1222.765

1536.945

1815.171

 

 

25.694

18.103

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1222.765

1536.945

1815.171

Profit

48.114

94.385

144.405

 

3.93%

6.14%

7.96%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on

31.03.2013

As on

31.03.2012

LONG TERM BORROWINGS

 

 

Loans and advance from directors

17.919

24.977

 

 

 

Total

17.919

24.977

 

Note: The Registered Office of the company has been shifted from 603, A Dalamal Chembers, New Marine Lines, 6th Road, Mumbai – 400020, Maharashtra, India to the present address w.e.f. 01.11.2007.

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

80015564

02/11/2006 *

90,000,000.00

ABN AMRO BANK N. V.

7TH FLOOR, SAKHAR BHAVAN, NARIMAN POINT, MUMBAI, 
MAHARASHTRA - 400021, INDIA

-

 

* Date of charge modification

 

FIXED ASSETS

 

·         Buildings

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Motor vehicles

·         Office equipment

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.06

UK Pound

1

Rs.101.84

Euro

1

Rs. 81.56

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

DPH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.